nodes	percent_of_prediction	percent_of_DWPC	metapath
Glyburide—ALB—Auranofin—psoriatic arthritis	0.101	0.114	CbGbCtD
Glyburide—SLCO1A2—Prednisolone—psoriatic arthritis	0.0656	0.0744	CbGbCtD
Glyburide—SLCO1A2—Prednisone—psoriatic arthritis	0.062	0.0702	CbGbCtD
Glyburide—ABCB11—Dexamethasone—psoriatic arthritis	0.061	0.0691	CbGbCtD
Glyburide—ABCC3—Methotrexate—psoriatic arthritis	0.0567	0.0643	CbGbCtD
Glyburide—SLC22A7—Methotrexate—psoriatic arthritis	0.0444	0.0503	CbGbCtD
Glyburide—SLCO1A2—Dexamethasone—psoriatic arthritis	0.0387	0.0438	CbGbCtD
Glyburide—ABCC1—Methotrexate—psoriatic arthritis	0.0348	0.0395	CbGbCtD
Glyburide—ABCC2—Dexamethasone—psoriatic arthritis	0.0321	0.0363	CbGbCtD
Glyburide—ALB—Prednisone—psoriatic arthritis	0.032	0.0363	CbGbCtD
Glyburide—SLCO1A2—Methotrexate—psoriatic arthritis	0.0311	0.0352	CbGbCtD
Glyburide—ABCG2—Dexamethasone—psoriatic arthritis	0.029	0.0329	CbGbCtD
Glyburide—ABCB1—Methylprednisolone—psoriatic arthritis	0.0277	0.0313	CbGbCtD
Glyburide—ABCC2—Methotrexate—psoriatic arthritis	0.0258	0.0292	CbGbCtD
Glyburide—ABCG2—Methotrexate—psoriatic arthritis	0.0233	0.0264	CbGbCtD
Glyburide—CYP2C19—Prednisone—psoriatic arthritis	0.0208	0.0235	CbGbCtD
Glyburide—SLC22A6—Methotrexate—psoriatic arthritis	0.0189	0.0214	CbGbCtD
Glyburide—ABCB1—Betamethasone—psoriatic arthritis	0.018	0.0204	CbGbCtD
Glyburide—ABCB1—Prednisolone—psoriatic arthritis	0.0177	0.0201	CbGbCtD
Glyburide—ABCB1—Prednisone—psoriatic arthritis	0.0168	0.019	CbGbCtD
Glyburide—CYP3A4—Methylprednisolone—psoriatic arthritis	0.0166	0.0188	CbGbCtD
Glyburide—ALB—Methotrexate—psoriatic arthritis	0.0161	0.0182	CbGbCtD
Glyburide—CYP2C19—Dexamethasone—psoriatic arthritis	0.013	0.0147	CbGbCtD
Glyburide—CYP3A4—Triamcinolone—psoriatic arthritis	0.0126	0.0142	CbGbCtD
Glyburide—CYP2C9—Dexamethasone—psoriatic arthritis	0.0108	0.0122	CbGbCtD
Glyburide—CYP3A4—Betamethasone—psoriatic arthritis	0.0108	0.0122	CbGbCtD
Glyburide—CYP3A4—Prednisolone—psoriatic arthritis	0.0106	0.012	CbGbCtD
Glyburide—ABCB1—Dexamethasone—psoriatic arthritis	0.0105	0.0118	CbGbCtD
Glyburide—CYP3A4—Prednisone—psoriatic arthritis	0.01	0.0114	CbGbCtD
Glyburide—ABCB1—Methotrexate—psoriatic arthritis	0.00841	0.00952	CbGbCtD
Glyburide—CYP3A4—Dexamethasone—psoriatic arthritis	0.00627	0.0071	CbGbCtD
Glyburide—Dyspepsia—Auranofin—psoriatic arthritis	0.000876	0.00748	CcSEcCtD
Glyburide—Decreased appetite—Auranofin—psoriatic arthritis	0.000865	0.00738	CcSEcCtD
Glyburide—Encephalopathy—Methotrexate—psoriatic arthritis	0.000841	0.00718	CcSEcCtD
Glyburide—Vasculitis—Triamcinolone—psoriatic arthritis	0.000838	0.00715	CcSEcCtD
Glyburide—Vasculitis—Methylprednisolone—psoriatic arthritis	0.000836	0.00714	CcSEcCtD
Glyburide—Gastrointestinal pain—Auranofin—psoriatic arthritis	0.000814	0.00695	CcSEcCtD
Glyburide—Urticaria—Auranofin—psoriatic arthritis	0.000791	0.00675	CcSEcCtD
Glyburide—Abdominal pain—Auranofin—psoriatic arthritis	0.000787	0.00671	CcSEcCtD
Glyburide—Vasculitis—Betamethasone—psoriatic arthritis	0.00076	0.00649	CcSEcCtD
Glyburide—Vasculitis—Dexamethasone—psoriatic arthritis	0.00076	0.00649	CcSEcCtD
Glyburide—Pruritus—Auranofin—psoriatic arthritis	0.000704	0.00601	CcSEcCtD
Glyburide—Visual disturbance—Prednisolone—psoriatic arthritis	0.000681	0.00581	CcSEcCtD
Glyburide—Diarrhoea—Auranofin—psoriatic arthritis	0.000681	0.00581	CcSEcCtD
Glyburide—Dermatitis bullous—Prednisolone—psoriatic arthritis	0.000676	0.00577	CcSEcCtD
Glyburide—Vascular purpura—Triamcinolone—psoriatic arthritis	0.000664	0.00566	CcSEcCtD
Glyburide—Vasculitis—Prednisone—psoriatic arthritis	0.000662	0.00565	CcSEcCtD
Glyburide—Vomiting—Auranofin—psoriatic arthritis	0.000633	0.0054	CcSEcCtD
Glyburide—Rash—Auranofin—psoriatic arthritis	0.000627	0.00536	CcSEcCtD
Glyburide—Dermatitis—Auranofin—psoriatic arthritis	0.000627	0.00535	CcSEcCtD
Glyburide—Dermatitis bullous—Triamcinolone—psoriatic arthritis	0.000621	0.0053	CcSEcCtD
Glyburide—Purpura—Triamcinolone—psoriatic arthritis	0.000616	0.00526	CcSEcCtD
Glyburide—Hyperbilirubinaemia—Methotrexate—psoriatic arthritis	0.000594	0.00507	CcSEcCtD
Glyburide—Nausea—Auranofin—psoriatic arthritis	0.000591	0.00505	CcSEcCtD
Glyburide—Visual disturbance—Betamethasone—psoriatic arthritis	0.000568	0.00485	CcSEcCtD
Glyburide—Visual disturbance—Dexamethasone—psoriatic arthritis	0.000568	0.00485	CcSEcCtD
Glyburide—Dermatitis bullous—Dexamethasone—psoriatic arthritis	0.000564	0.00481	CcSEcCtD
Glyburide—Dermatitis bullous—Betamethasone—psoriatic arthritis	0.000564	0.00481	CcSEcCtD
Glyburide—Abdominal distension—Prednisolone—psoriatic arthritis	0.000562	0.00479	CcSEcCtD
Glyburide—Vasculitis—Methotrexate—psoriatic arthritis	0.000553	0.00472	CcSEcCtD
Glyburide—Pancreatitis—Prednisolone—psoriatic arthritis	0.000547	0.00467	CcSEcCtD
Glyburide—Sweating increased—Prednisolone—psoriatic arthritis	0.000544	0.00464	CcSEcCtD
Glyburide—Vascular purpura—Prednisone—psoriatic arthritis	0.000524	0.00448	CcSEcCtD
Glyburide—Abdominal distension—Triamcinolone—psoriatic arthritis	0.000517	0.00441	CcSEcCtD
Glyburide—Abdominal distension—Methylprednisolone—psoriatic arthritis	0.000515	0.0044	CcSEcCtD
Glyburide—Aplastic anaemia—Methotrexate—psoriatic arthritis	0.000507	0.00433	CcSEcCtD
Glyburide—Pancreatitis—Triamcinolone—psoriatic arthritis	0.000503	0.00429	CcSEcCtD
Glyburide—Pancreatitis—Methylprednisolone—psoriatic arthritis	0.000502	0.00428	CcSEcCtD
Glyburide—Sweating increased—Triamcinolone—psoriatic arthritis	0.0005	0.00427	CcSEcCtD
Glyburide—Sweating increased—Methylprednisolone—psoriatic arthritis	0.000499	0.00426	CcSEcCtD
Glyburide—Purpura—Prednisone—psoriatic arthritis	0.000487	0.00415	CcSEcCtD
Glyburide—Sweating increased—Dexamethasone—psoriatic arthritis	0.000454	0.00387	CcSEcCtD
Glyburide—Sweating increased—Betamethasone—psoriatic arthritis	0.000454	0.00387	CcSEcCtD
Glyburide—Hepatic failure—Methotrexate—psoriatic arthritis	0.000436	0.00372	CcSEcCtD
Glyburide—Visual impairment—Prednisolone—psoriatic arthritis	0.00043	0.00367	CcSEcCtD
Glyburide—Renal failure acute—Methotrexate—psoriatic arthritis	0.000425	0.00362	CcSEcCtD
Glyburide—Visual disturbance—Methotrexate—psoriatic arthritis	0.000414	0.00353	CcSEcCtD
Glyburide—Abdominal distension—Prednisone—psoriatic arthritis	0.000408	0.00348	CcSEcCtD
Glyburide—Pancreatitis—Prednisone—psoriatic arthritis	0.000398	0.00339	CcSEcCtD
Glyburide—Sweating increased—Prednisone—psoriatic arthritis	0.000395	0.00337	CcSEcCtD
Glyburide—Visual impairment—Methylprednisolone—psoriatic arthritis	0.000395	0.00337	CcSEcCtD
Glyburide—Erythema—Prednisolone—psoriatic arthritis	0.000389	0.00332	CcSEcCtD
Glyburide—Eye disorder—Methylprednisolone—psoriatic arthritis	0.000383	0.00327	CcSEcCtD
Glyburide—Vision blurred—Prednisolone—psoriatic arthritis	0.000366	0.00313	CcSEcCtD
Glyburide—Visual impairment—Dexamethasone—psoriatic arthritis	0.000359	0.00307	CcSEcCtD
Glyburide—Visual impairment—Betamethasone—psoriatic arthritis	0.000359	0.00307	CcSEcCtD
Glyburide—Erythema—Triamcinolone—psoriatic arthritis	0.000358	0.00305	CcSEcCtD
Glyburide—Erythema—Methylprednisolone—psoriatic arthritis	0.000357	0.00304	CcSEcCtD
Glyburide—Malnutrition—Methylprednisolone—psoriatic arthritis	0.000357	0.00304	CcSEcCtD
Glyburide—Angioedema—Prednisolone—psoriatic arthritis	0.000355	0.00303	CcSEcCtD
Glyburide—Eye disorder—Betamethasone—psoriatic arthritis	0.000348	0.00297	CcSEcCtD
Glyburide—Eye disorder—Dexamethasone—psoriatic arthritis	0.000348	0.00297	CcSEcCtD
Glyburide—Convulsion—Prednisolone—psoriatic arthritis	0.000337	0.00288	CcSEcCtD
Glyburide—Eosinophilia—Methotrexate—psoriatic arthritis	0.000336	0.00286	CcSEcCtD
Glyburide—Pancreatitis—Methotrexate—psoriatic arthritis	0.000332	0.00284	CcSEcCtD
Glyburide—Alopecia—Betamethasone—psoriatic arthritis	0.000329	0.00281	CcSEcCtD
Glyburide—Alopecia—Dexamethasone—psoriatic arthritis	0.000329	0.00281	CcSEcCtD
Glyburide—Angioedema—Triamcinolone—psoriatic arthritis	0.000327	0.00279	CcSEcCtD
Glyburide—Angioedema—Methylprednisolone—psoriatic arthritis	0.000326	0.00278	CcSEcCtD
Glyburide—Erythema—Betamethasone—psoriatic arthritis	0.000324	0.00277	CcSEcCtD
Glyburide—Erythema—Dexamethasone—psoriatic arthritis	0.000324	0.00277	CcSEcCtD
Glyburide—Pancytopenia—Methotrexate—psoriatic arthritis	0.000322	0.00275	CcSEcCtD
Glyburide—Oedema—Prednisolone—psoriatic arthritis	0.000317	0.00271	CcSEcCtD
Glyburide—Shock—Prednisolone—psoriatic arthritis	0.000312	0.00266	CcSEcCtD
Glyburide—Convulsion—Triamcinolone—psoriatic arthritis	0.00031	0.00264	CcSEcCtD
Glyburide—Photosensitivity reaction—Methotrexate—psoriatic arthritis	0.000309	0.00264	CcSEcCtD
Glyburide—Convulsion—Methylprednisolone—psoriatic arthritis	0.000309	0.00264	CcSEcCtD
Glyburide—Hyperhidrosis—Prednisolone—psoriatic arthritis	0.000307	0.00262	CcSEcCtD
Glyburide—Myalgia—Triamcinolone—psoriatic arthritis	0.000304	0.0026	CcSEcCtD
Glyburide—Myalgia—Methylprednisolone—psoriatic arthritis	0.000304	0.00259	CcSEcCtD
Glyburide—Arthralgia—Methylprednisolone—psoriatic arthritis	0.000304	0.00259	CcSEcCtD
Glyburide—Eye disorder—Prednisone—psoriatic arthritis	0.000303	0.00259	CcSEcCtD
Glyburide—Angioedema—Dexamethasone—psoriatic arthritis	0.000296	0.00253	CcSEcCtD
Glyburide—Angioedema—Betamethasone—psoriatic arthritis	0.000296	0.00253	CcSEcCtD
Glyburide—Confusional state—Methylprednisolone—psoriatic arthritis	0.000294	0.00251	CcSEcCtD
Glyburide—Oedema—Triamcinolone—psoriatic arthritis	0.000292	0.00249	CcSEcCtD
Glyburide—Shock—Triamcinolone—psoriatic arthritis	0.000287	0.00245	CcSEcCtD
Glyburide—Alopecia—Prednisone—psoriatic arthritis	0.000287	0.00245	CcSEcCtD
Glyburide—Shock—Methylprednisolone—psoriatic arthritis	0.000286	0.00244	CcSEcCtD
Glyburide—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.000286	0.00244	CcSEcCtD
Glyburide—Paraesthesia—Prednisolone—psoriatic arthritis	0.000285	0.00243	CcSEcCtD
Glyburide—Malnutrition—Prednisone—psoriatic arthritis	0.000283	0.00241	CcSEcCtD
Glyburide—Erythema—Prednisone—psoriatic arthritis	0.000283	0.00241	CcSEcCtD
Glyburide—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.000282	0.00241	CcSEcCtD
Glyburide—Agranulocytosis—Methotrexate—psoriatic arthritis	0.000282	0.00241	CcSEcCtD
Glyburide—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.000281	0.0024	CcSEcCtD
Glyburide—Convulsion—Dexamethasone—psoriatic arthritis	0.000281	0.0024	CcSEcCtD
Glyburide—Convulsion—Betamethasone—psoriatic arthritis	0.000281	0.0024	CcSEcCtD
Glyburide—Myalgia—Betamethasone—psoriatic arthritis	0.000276	0.00236	CcSEcCtD
Glyburide—Myalgia—Dexamethasone—psoriatic arthritis	0.000276	0.00236	CcSEcCtD
Glyburide—Hypotension—Methylprednisolone—psoriatic arthritis	0.000272	0.00232	CcSEcCtD
Glyburide—Hepatitis—Methotrexate—psoriatic arthritis	0.000271	0.00232	CcSEcCtD
Glyburide—Vision blurred—Prednisone—psoriatic arthritis	0.000266	0.00227	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.000266	0.00227	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.000265	0.00226	CcSEcCtD
Glyburide—Oedema—Betamethasone—psoriatic arthritis	0.000265	0.00226	CcSEcCtD
Glyburide—Oedema—Dexamethasone—psoriatic arthritis	0.000265	0.00226	CcSEcCtD
Glyburide—Paraesthesia—Triamcinolone—psoriatic arthritis	0.000262	0.00224	CcSEcCtD
Glyburide—Feeling abnormal—Prednisolone—psoriatic arthritis	0.000261	0.00223	CcSEcCtD
Glyburide—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.000261	0.00223	CcSEcCtD
Glyburide—Visual impairment—Methotrexate—psoriatic arthritis	0.000261	0.00223	CcSEcCtD
Glyburide—Anaemia—Prednisone—psoriatic arthritis	0.000261	0.00223	CcSEcCtD
Glyburide—Shock—Dexamethasone—psoriatic arthritis	0.00026	0.00222	CcSEcCtD
Glyburide—Shock—Betamethasone—psoriatic arthritis	0.00026	0.00222	CcSEcCtD
Glyburide—Dyspnoea—Triamcinolone—psoriatic arthritis	0.00026	0.00222	CcSEcCtD
Glyburide—Nervous system disorder—Betamethasone—psoriatic arthritis	0.00026	0.00222	CcSEcCtD
Glyburide—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.00026	0.00222	CcSEcCtD
Glyburide—Thrombocytopenia—Dexamethasone—psoriatic arthritis	0.000259	0.00221	CcSEcCtD
Glyburide—Thrombocytopenia—Betamethasone—psoriatic arthritis	0.000259	0.00221	CcSEcCtD
Glyburide—Angioedema—Prednisone—psoriatic arthritis	0.000258	0.0022	CcSEcCtD
Glyburide—Dyspepsia—Triamcinolone—psoriatic arthritis	0.000257	0.00219	CcSEcCtD
Glyburide—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.000256	0.00219	CcSEcCtD
Glyburide—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.000256	0.00218	CcSEcCtD
Glyburide—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.000256	0.00218	CcSEcCtD
Glyburide—Eye disorder—Methotrexate—psoriatic arthritis	0.000253	0.00216	CcSEcCtD
Glyburide—Anorexia—Betamethasone—psoriatic arthritis	0.000252	0.00215	CcSEcCtD
Glyburide—Anorexia—Dexamethasone—psoriatic arthritis	0.000252	0.00215	CcSEcCtD
Glyburide—Urticaria—Prednisolone—psoriatic arthritis	0.000252	0.00215	CcSEcCtD
Glyburide—Hypotension—Betamethasone—psoriatic arthritis	0.000247	0.00211	CcSEcCtD
Glyburide—Hypotension—Dexamethasone—psoriatic arthritis	0.000247	0.00211	CcSEcCtD
Glyburide—Convulsion—Prednisone—psoriatic arthritis	0.000245	0.00209	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.000241	0.00206	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.000241	0.00206	CcSEcCtD
Glyburide—Arthralgia—Prednisone—psoriatic arthritis	0.000241	0.00205	CcSEcCtD
Glyburide—Myalgia—Prednisone—psoriatic arthritis	0.000241	0.00205	CcSEcCtD
Glyburide—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.00024	0.00205	CcSEcCtD
Glyburide—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.00024	0.00205	CcSEcCtD
Glyburide—Alopecia—Methotrexate—psoriatic arthritis	0.00024	0.00205	CcSEcCtD
Glyburide—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.000238	0.00203	CcSEcCtD
Glyburide—Paraesthesia—Dexamethasone—psoriatic arthritis	0.000238	0.00203	CcSEcCtD
Glyburide—Paraesthesia—Betamethasone—psoriatic arthritis	0.000238	0.00203	CcSEcCtD
Glyburide—Erythema—Methotrexate—psoriatic arthritis	0.000236	0.00202	CcSEcCtD
Glyburide—Malnutrition—Methotrexate—psoriatic arthritis	0.000236	0.00202	CcSEcCtD
Glyburide—Hypersensitivity—Prednisolone—psoriatic arthritis	0.000234	0.002	CcSEcCtD
Glyburide—Dyspepsia—Dexamethasone—psoriatic arthritis	0.000233	0.00199	CcSEcCtD
Glyburide—Dyspepsia—Betamethasone—psoriatic arthritis	0.000233	0.00199	CcSEcCtD
Glyburide—Urticaria—Triamcinolone—psoriatic arthritis	0.000232	0.00198	CcSEcCtD
Glyburide—Urticaria—Methylprednisolone—psoriatic arthritis	0.000231	0.00197	CcSEcCtD
Glyburide—Oedema—Prednisone—psoriatic arthritis	0.000231	0.00197	CcSEcCtD
Glyburide—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.00023	0.00196	CcSEcCtD
Glyburide—Decreased appetite—Dexamethasone—psoriatic arthritis	0.00023	0.00196	CcSEcCtD
Glyburide—Decreased appetite—Betamethasone—psoriatic arthritis	0.00023	0.00196	CcSEcCtD
Glyburide—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.000229	0.00195	CcSEcCtD
Glyburide—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.000229	0.00195	CcSEcCtD
Glyburide—Shock—Prednisone—psoriatic arthritis	0.000227	0.00194	CcSEcCtD
Glyburide—Nervous system disorder—Prednisone—psoriatic arthritis	0.000226	0.00193	CcSEcCtD
Glyburide—Hyperhidrosis—Prednisone—psoriatic arthritis	0.000223	0.0019	CcSEcCtD
Glyburide—Vision blurred—Methotrexate—psoriatic arthritis	0.000223	0.0019	CcSEcCtD
Glyburide—Anorexia—Prednisone—psoriatic arthritis	0.00022	0.00188	CcSEcCtD
Glyburide—Anaemia—Methotrexate—psoriatic arthritis	0.000218	0.00186	CcSEcCtD
Glyburide—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.000218	0.00186	CcSEcCtD
Glyburide—Feeling abnormal—Betamethasone—psoriatic arthritis	0.000218	0.00186	CcSEcCtD
Glyburide—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.000217	0.00185	CcSEcCtD
Glyburide—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.000217	0.00185	CcSEcCtD
Glyburide—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.000215	0.00184	CcSEcCtD
Glyburide—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.000215	0.00183	CcSEcCtD
Glyburide—Leukopenia—Methotrexate—psoriatic arthritis	0.000211	0.0018	CcSEcCtD
Glyburide—Urticaria—Betamethasone—psoriatic arthritis	0.00021	0.0018	CcSEcCtD
Glyburide—Urticaria—Dexamethasone—psoriatic arthritis	0.00021	0.0018	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.00021	0.00179	CcSEcCtD
Glyburide—Asthenia—Triamcinolone—psoriatic arthritis	0.000209	0.00179	CcSEcCtD
Glyburide—Abdominal pain—Dexamethasone—psoriatic arthritis	0.000209	0.00179	CcSEcCtD
Glyburide—Abdominal pain—Betamethasone—psoriatic arthritis	0.000209	0.00179	CcSEcCtD
Glyburide—Asthenia—Methylprednisolone—psoriatic arthritis	0.000209	0.00178	CcSEcCtD
Glyburide—Paraesthesia—Prednisone—psoriatic arthritis	0.000207	0.00177	CcSEcCtD
Glyburide—Pruritus—Triamcinolone—psoriatic arthritis	0.000206	0.00176	CcSEcCtD
Glyburide—Pruritus—Methylprednisolone—psoriatic arthritis	0.000206	0.00176	CcSEcCtD
Glyburide—Convulsion—Methotrexate—psoriatic arthritis	0.000205	0.00175	CcSEcCtD
Glyburide—Dyspepsia—Prednisone—psoriatic arthritis	0.000203	0.00173	CcSEcCtD
Glyburide—Myalgia—Methotrexate—psoriatic arthritis	0.000201	0.00172	CcSEcCtD
Glyburide—Arthralgia—Methotrexate—psoriatic arthritis	0.000201	0.00172	CcSEcCtD
Glyburide—Decreased appetite—Prednisone—psoriatic arthritis	0.0002	0.00171	CcSEcCtD
Glyburide—Rash—Prednisolone—psoriatic arthritis	0.0002	0.00171	CcSEcCtD
Glyburide—Dermatitis—Prednisolone—psoriatic arthritis	0.0002	0.00171	CcSEcCtD
Glyburide—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.000199	0.0017	CcSEcCtD
Glyburide—Headache—Prednisolone—psoriatic arthritis	0.000199	0.0017	CcSEcCtD
Glyburide—Confusional state—Methotrexate—psoriatic arthritis	0.000194	0.00166	CcSEcCtD
Glyburide—Feeling abnormal—Prednisone—psoriatic arthritis	0.00019	0.00162	CcSEcCtD
Glyburide—Asthenia—Betamethasone—psoriatic arthritis	0.00019	0.00162	CcSEcCtD
Glyburide—Asthenia—Dexamethasone—psoriatic arthritis	0.00019	0.00162	CcSEcCtD
Glyburide—Nervous system disorder—Methotrexate—psoriatic arthritis	0.000189	0.00161	CcSEcCtD
Glyburide—Thrombocytopenia—Methotrexate—psoriatic arthritis	0.000189	0.00161	CcSEcCtD
Glyburide—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.000189	0.00161	CcSEcCtD
Glyburide—Nausea—Prednisolone—psoriatic arthritis	0.000188	0.00161	CcSEcCtD
Glyburide—Pruritus—Betamethasone—psoriatic arthritis	0.000187	0.0016	CcSEcCtD
Glyburide—Pruritus—Dexamethasone—psoriatic arthritis	0.000187	0.0016	CcSEcCtD
Glyburide—Hyperhidrosis—Methotrexate—psoriatic arthritis	0.000186	0.00159	CcSEcCtD
Glyburide—Vomiting—Triamcinolone—psoriatic arthritis	0.000186	0.00158	CcSEcCtD
Glyburide—Vomiting—Methylprednisolone—psoriatic arthritis	0.000185	0.00158	CcSEcCtD
Glyburide—Rash—Triamcinolone—psoriatic arthritis	0.000184	0.00157	CcSEcCtD
Glyburide—Dermatitis—Triamcinolone—psoriatic arthritis	0.000184	0.00157	CcSEcCtD
Glyburide—Anorexia—Methotrexate—psoriatic arthritis	0.000184	0.00157	CcSEcCtD
Glyburide—Rash—Methylprednisolone—psoriatic arthritis	0.000184	0.00157	CcSEcCtD
Glyburide—Dermatitis—Methylprednisolone—psoriatic arthritis	0.000183	0.00157	CcSEcCtD
Glyburide—Urticaria—Prednisone—psoriatic arthritis	0.000183	0.00156	CcSEcCtD
Glyburide—Headache—Triamcinolone—psoriatic arthritis	0.000183	0.00156	CcSEcCtD
Glyburide—Headache—Methylprednisolone—psoriatic arthritis	0.000182	0.00156	CcSEcCtD
Glyburide—Abdominal pain—Prednisone—psoriatic arthritis	0.000182	0.00156	CcSEcCtD
Glyburide—Diarrhoea—Betamethasone—psoriatic arthritis	0.000181	0.00155	CcSEcCtD
Glyburide—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000181	0.00155	CcSEcCtD
Glyburide—Hypotension—Methotrexate—psoriatic arthritis	0.00018	0.00154	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.000176	0.0015	CcSEcCtD
Glyburide—Nausea—Triamcinolone—psoriatic arthritis	0.000173	0.00148	CcSEcCtD
Glyburide—Paraesthesia—Methotrexate—psoriatic arthritis	0.000173	0.00148	CcSEcCtD
Glyburide—Nausea—Methylprednisolone—psoriatic arthritis	0.000173	0.00148	CcSEcCtD
Glyburide—Dyspnoea—Methotrexate—psoriatic arthritis	0.000172	0.00147	CcSEcCtD
Glyburide—Hypersensitivity—Prednisone—psoriatic arthritis	0.00017	0.00145	CcSEcCtD
Glyburide—Dyspepsia—Methotrexate—psoriatic arthritis	0.00017	0.00145	CcSEcCtD
Glyburide—Vomiting—Betamethasone—psoriatic arthritis	0.000168	0.00144	CcSEcCtD
Glyburide—Vomiting—Dexamethasone—psoriatic arthritis	0.000168	0.00144	CcSEcCtD
Glyburide—Decreased appetite—Methotrexate—psoriatic arthritis	0.000168	0.00143	CcSEcCtD
Glyburide—Rash—Dexamethasone—psoriatic arthritis	0.000167	0.00142	CcSEcCtD
Glyburide—Rash—Betamethasone—psoriatic arthritis	0.000167	0.00142	CcSEcCtD
Glyburide—Dermatitis—Dexamethasone—psoriatic arthritis	0.000167	0.00142	CcSEcCtD
Glyburide—Dermatitis—Betamethasone—psoriatic arthritis	0.000167	0.00142	CcSEcCtD
Glyburide—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.000166	0.00142	CcSEcCtD
Glyburide—Headache—Dexamethasone—psoriatic arthritis	0.000166	0.00142	CcSEcCtD
Glyburide—Headache—Betamethasone—psoriatic arthritis	0.000166	0.00142	CcSEcCtD
Glyburide—Asthenia—Prednisone—psoriatic arthritis	0.000165	0.00141	CcSEcCtD
Glyburide—Pruritus—Prednisone—psoriatic arthritis	0.000163	0.00139	CcSEcCtD
Glyburide—Feeling abnormal—Methotrexate—psoriatic arthritis	0.000159	0.00136	CcSEcCtD
Glyburide—Diarrhoea—Prednisone—psoriatic arthritis	0.000158	0.00135	CcSEcCtD
Glyburide—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.000158	0.00134	CcSEcCtD
Glyburide—Nausea—Dexamethasone—psoriatic arthritis	0.000157	0.00134	CcSEcCtD
Glyburide—Nausea—Betamethasone—psoriatic arthritis	0.000157	0.00134	CcSEcCtD
Glyburide—Urticaria—Methotrexate—psoriatic arthritis	0.000153	0.00131	CcSEcCtD
Glyburide—Abdominal pain—Methotrexate—psoriatic arthritis	0.000152	0.0013	CcSEcCtD
Glyburide—Vomiting—Prednisone—psoriatic arthritis	0.000147	0.00125	CcSEcCtD
Glyburide—Rash—Prednisone—psoriatic arthritis	0.000145	0.00124	CcSEcCtD
Glyburide—Dermatitis—Prednisone—psoriatic arthritis	0.000145	0.00124	CcSEcCtD
Glyburide—Headache—Prednisone—psoriatic arthritis	0.000144	0.00123	CcSEcCtD
Glyburide—Hypersensitivity—Methotrexate—psoriatic arthritis	0.000142	0.00121	CcSEcCtD
Glyburide—Asthenia—Methotrexate—psoriatic arthritis	0.000138	0.00118	CcSEcCtD
Glyburide—Nausea—Prednisone—psoriatic arthritis	0.000137	0.00117	CcSEcCtD
Glyburide—Pruritus—Methotrexate—psoriatic arthritis	0.000136	0.00116	CcSEcCtD
Glyburide—Diarrhoea—Methotrexate—psoriatic arthritis	0.000132	0.00113	CcSEcCtD
Glyburide—Vomiting—Methotrexate—psoriatic arthritis	0.000123	0.00105	CcSEcCtD
Glyburide—Rash—Methotrexate—psoriatic arthritis	0.000122	0.00104	CcSEcCtD
Glyburide—Dermatitis—Methotrexate—psoriatic arthritis	0.000121	0.00104	CcSEcCtD
Glyburide—Headache—Methotrexate—psoriatic arthritis	0.000121	0.00103	CcSEcCtD
Glyburide—Nausea—Methotrexate—psoriatic arthritis	0.000114	0.000977	CcSEcCtD
